Reanalysis of Popular Antidepressant Trial Uncovers Reporting Flaws
Dr. Joseph Mercola - Take Control of Your Health · Dr. Joseph Mercola
September 16, 20258m 14s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
- A reanalysis of a study found that fluoxetine alone showed no measurable benefit over placebo in treating adolescent depression after 12 weeks
- Researchers uncovered 11 additional suicide-related events that were hidden or misclassified, bringing the total to 21 serious incidents
- Statistical tactics and selective reporting made fluoxetine appear safer and more effective than it really was in clinical trials
- A different reanalysis mentioned that adverse events and many side effects were minimized or excluded from the original reports
- Improving gut health, getting regular exercise, undergoing therapy, and optimizing vitamin D are viable approaches for treating depression